Urgent.News

One page, thousands of outlets. See who else covered it.

Editions

Finance & Markets

PolyPid (PYPD) Q2 2026 Earnings Call Transcript

FDA accepts D-PLEX100 application with Priority Review, setting November approval target.

We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.

This story

This is one outlet's version. Read the fullest account.

Read the original at fool.com →

More in Finance & Markets

More from Wednesday 19 August →